Lee et al. [35] previously provided direct evidence that B. fragilis inhibits colitis-associated CRC by producing polysaccharide A (PSA) and further activating the Toll-like receptor 2 (TLR2) signaling in murine models. This evidence concerns the gene TLR2 and colorectal carcinoma.